RNA, U5E small nuclear 5, pseudogene (RNU5E-5P)

RNA, U5E small nuclear 5, pseudogene (RNU5E-5P) is a human gene classified as a *pseudogene* of the small nuclear RNA family. It does not encode a functional product but is related in sequence to U5 small nuclear RNAs (snRNAs), which are components of the spliceosome, a complex responsible for the removal of introns during pre-mRNA splicing. Unlike the functional U5 snRNAs (encoded by RNU5A-1, RNU5B-1, etc.), RNU5E-5P lacks evidence of functional expression or biological activity and is presumed to be transcriptionally inactive[2][4][5]. While parent U5 snRNAs are essential for aligning exons and catalyzing the splicing process, and their mutations can cause severe spliceosome-related disorders, there is no evidence that this pseudogene variant plays any direct role in human biology or disease[5]. Summary context: - This molecule is not a *receptor*, *enzyme*, or other classical therapeutic target, and there is no evidence it is actively expressed or functionally relevant in disease or as a drug target. - The presence of "pseudogene" in its name and gene annotation indicates it should not be considered an active molecular target for therapy, biomarker development, or safety assessment[2][4]. - Information or actions related to drugs or mechanisms of action are not applicable in this context since there is no demonstrated biological activity or disease involvement for RNU5E-5P. If further structured drug discovery or molecular target annotation is required, focus should instead be on the functional U5 snRNA genes, such as RNU5A-1 or RNU5B-1, not on pseudogenes like RNU5E-5P[5].

Other names

RNU5E-5PU5E small nuclear RNA pseudogeneSNORDU5E-5P